Nilotinib (
Tasigna®) is a prescription medication approved to treat chronic myeloid
leukemia (
CML), a type of cancer that affects the blood and bone marrow. It belongs to a group of medicines known as
tyrosine kinase inhibitors. Nilotinib is used in people who are newly diagnosed with leukemia, or those who are no longer benefiting from or cannot tolerate
imatinib (
Gleevec®), another tyrosine kinase inhibitor medication.
Just like any medicine, nilotinib can cause side effects.
Although not everyone who uses the drug will have problems, most people will experience some type of nilotinib side effect during treatment.
If reactions do occur, in most cases, they are mild or moderate in severity and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of nilotinib include but are not limited to:
(Click Nilotinib Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)